ARCHIVES

OMB Restrictions On Reprogramming Could Result In Inefficient Last Minute Spending By Institutes

This article is from The Cancer Letter archive.

Vol. 11 No. 35 | September 13, 1985

Download PDF Visit The Full Archive

Related Articles

ACS Board allocated $37.5 Million to Research; More Coming

February 20, 1987

PRI Asks NIH To Cancel Recompetition Of Frederick Center Operations Contract

February 17, 1995

New Core Gant Guideline Proposals Drawn Up; Opposition Developing Among Center Directors

April 4, 1980

Clinical Trials: NCI Forms Panel To Help Implement Recommendations

December 12, 1997

Degarelix Approved For Advanced Prostate Cancer

January 30, 2009

WHI Update: No Increased Risk Of Cancer With Estrogen-Alone

April 28, 2006